Mr. Elad Bibi-Aviv reports

SEEGNAL ANNOUNCES LISTING ON THE FRANKFURT STOCK EXCHANGE

Seegnal Inc.'s common shares will commence trading on the Frankfurt Stock Exchange today, July 10, 2026, under the ticker symbol 2I1 (WKN: A41FV7).

The company's common shares will continue to trade on the TSX Venture Exchange under the symbol SEGN (ISIN: CA81573E1060).

The Frankfurt Stock Exchange is one of the world's largest and most established trading venues by market capitalization and is operated by Deutsche Borse AG. The company's stock quotation on the FSE is expected to increase the company's visibility and accessibility among European and international investors.

About Seegnal Inc.

Seegnal is an innovative health care technology company dedicated to reducing medication-related harm where care begins. The company's software-as-a-service-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing and advance a more personalized standard of patient care. Seegnal's technology is deployed across health care settings and is used by approximately 15,000 clinicians in daily practice.

We seek Safe Harbor.